Protalix Biotherapeutics Inc (PLX) has gained Thursday morning, with the stock gaining 1.76% in pre-market trading to 1.73. PLX's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, the stock ranks higher than 41% of stocks. Protalix Biotherapeutics Inc has risen 5.59% over the past month, closing at $1.48 on August 12. During this period of time, the stock fell as low as $1.31 and as high as $1.78. PLX has an average analyst recommendation of Strong Buy. The company has an average price target of $9.75.
Protalix Biotherapeutics Inc has a Long-Term Technical rank of 6. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 94% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, PLX ranks better than 15% of stocks.
Protalix Biotherapeutics Inc (PLX) Up 1.76% in Premarket Trading
PLX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on PLX!